{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:00:14Z","timestamp":1758045614832,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo","doi-asserted-by":"publisher","award":["2019A610228"],"award-info":[{"award-number":["2019A610228"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LBY22H180004"],"award-info":[{"award-number":["LBY22H180004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.amjms.2022.12.001","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T20:07:40Z","timestamp":1670875660000},"page":"429-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical and HRCT features of amyopathic dermatomyositis associated with interstitial lung disease: A retrospective study of 128 patients with connective tissue disease-related interstitial lung disease"],"prefix":"10.1016","volume":"365","author":[{"given":"Tingting","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaichun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qunli","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.amjms.2022.12.001_bib0001","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.amjms.2022.12.001_bib0002","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","article-title":"Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients","volume":"63","author":"Marie","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.amjms.2022.12.001_bib0003","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/1756-185X.13559","article-title":"Overlap myositis, a distinct entity beyond primary inflammatory myositis: a retrospective analysis of a large cohort from the REMICAM registry","volume":"22","author":"Nuno-Nuno","year":"2019","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"10.1016\/j.amjms.2022.12.001_bib0004","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10067-018-4353-2","article-title":"Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease","volume":"38","author":"Cobo-Ibanez","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.amjms.2022.12.001_bib0005","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1067\/mjd.2002.120621","article-title":"Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?","volume":"46","author":"Sontheimer","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.amjms.2022.12.001_bib0006","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/rheumatology\/keaa372","article-title":"Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases","volume":"60","author":"Li","year":"2021","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.amjms.2022.12.001_bib0007","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archdermatol.2010.134","article-title":"Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations","volume":"146","author":"Morganroth","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.amjms.2022.12.001_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2018.05.010","article-title":"Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies","volume":"140","author":"Yamaguchi","year":"2018","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.amjms.2022.12.001_bib0009","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00296-012-2545-7","article-title":"Interstitial lung disease in clinically amyopathic dermatomyositis (CADM) patients: a retrospective study of 41 Chinese Han patients","volume":"33","author":"Sun","year":"2013","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.amjms.2022.12.001_bib0010","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/acr.22728","article-title":"Anti-melanoma differentiation-associated gene 5 is associated with rapidly progressive lung disease and poor survival in US Patients with amyopathic and myopathic dermatomyositis","volume":"68","author":"Moghadam-Kia","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"10","key":"10.1016\/j.amjms.2022.12.001_bib0011","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s10067-007-0562-9","article-title":"Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study","volume":"26","author":"Ye","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.amjms.2022.12.001_bib0012","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1378\/chest.08-2740","article-title":"Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis","volume":"136","author":"Mukae","year":"2009","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.amjms.2022.12.001_bib0013","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/acr.21985","article-title":"Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis","volume":"65","author":"Chen","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.amjms.2022.12.001_bib0014","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12890-017-0479-2","article-title":"Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias","volume":"17","author":"Okabayashi","year":"2017","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.amjms.2022.12.001_bib0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00296-015-3328-8","article-title":"Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease","volume":"36","author":"Go","year":"2016","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.amjms.2022.12.001_bib0016","first-page":"254","article-title":"Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute\/subacute interstitial pneumonia in dermatomyositis","volume":"35","author":"Kotani","year":"2008","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.amjms.2022.12.001_bib0017","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.amjms.2022.12.001_bib0018","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1056\/NEJMc1900045","article-title":"Tofacitinib in amyopathic dermatomyositis-associated interstitial lung disease","volume":"381","author":"Chen","year":"2019","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.amjms.2022.12.001_bib0019","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/rheumatology\/key188","article-title":"Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis","volume":"57","author":"Kurasawa","year":"2018","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.amjms.2022.12.001_bib0020","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/jamadermatol.2016.0866","article-title":"Tofacitinib citrate for refractory cutaneous dermatomyositis: an alternative treatment","volume":"152","author":"Kurtzman","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.amjms.2022.12.001_bib0021","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/CM9.0000000000000691","article-title":"Risk factors of interstitial lung diseases inclinically amyopathic dermatomyositis","author":"Gan","year":"2020","journal-title":"Chin Med J"},{"issue":"7","key":"10.1016\/j.amjms.2022.12.001_bib0022","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.rmed.2007.01.023","article-title":"Interstitial lung disease associated with amyopathic dermatomyositis: review of 18 cases","volume":"101","author":"Ideura","year":"2007","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.amjms.2022.12.001_bib0023","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.semarthrit.2020.03.007","article-title":"Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease","volume":"50","author":"Romero-Bueno","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.amjms.2022.12.001_bib0024","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.chest.2020.04.057","article-title":"Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease: the FLAIR model","volume":"158","author":"Lian","year":"2020","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.amjms.2022.12.001_bib0025","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10067-015-2866-5","article-title":"HRCT score and serum ferritin level are factors associated to the 1-year mortality of acute interstitial lung disease in clinically amyopathic dermatomyositis patients","volume":"34","author":"Zou","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.amjms.2022.12.001_bib0026","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1684\/ejd.2019.3634","article-title":"Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease","volume":"29","author":"Motegi","year":"2019","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.amjms.2022.12.001_bib0027","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/s10165-010-0362-y","article-title":"Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis","volume":"21","author":"Azuma","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"5","key":"10.1016\/j.amjms.2022.12.001_bib0028","first-page":"803","article-title":"Clinical features of thirty-two patients with anti-melanoma differentiation-associated gene 5 antibodies","volume":"37","author":"Huang","year":"2019","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.amjms.2022.12.001_bib0029","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10067-015-3139-z","article-title":"Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis","volume":"35","author":"Xu","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.amjms.2022.12.001_bib0030","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.rmed.2011.05.006","article-title":"HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody","volume":"105","author":"Tanizawa","year":"2011","journal-title":"Respir Med"},{"issue":"7","key":"10.1016\/j.amjms.2022.12.001_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/medicina57070692","article-title":"High-resolution CT findings of myositis-related interstitial lung disease","volume":"57","author":"Egashira","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.amjms.2022.12.001_bib0032","article-title":"Myositis specific antibodies are associated with isolated anti-Ro-52 associated interstitial lung disease","author":"Shao","year":"2021","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.amjms.2022.12.001_bib0033","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1007\/s11606-021-07131-7","article-title":"Anti-MDA5 antibody-associated clinically amyopathic dermatomyositis: case report and literature review","volume":"36","author":"Kersey","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"10","key":"10.1016\/j.amjms.2022.12.001_bib0034","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1093\/rheumatology\/keaa112","article-title":"Clinically amyopathic dermatomyositis with anti-transcriptional intermediary factor 1-gamma autoantibody positivity","volume":"59","author":"Kanaoka","year":"2020","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.amjms.2022.12.001_bib0035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e318260977c","article-title":"Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature","volume":"91","author":"Labirua-Iturburu","year":"2012","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.amjms.2022.12.001_bib0036","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s41927-021-00225-z","article-title":"Macrophage activation syndrome in MDA5 antibody-positive dermatomyositis and COVID-19 infection","volume":"5","author":"Keshtkarjahromi","year":"2021","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.amjms.2022.12.001_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.791348","article-title":"Presence of Anti-MDA5 antibody and its value for the clinical assessment in patients With COVID-19: a retrospective cohort study","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.amjms.2022.12.001_bib0038","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/24725625.2020.1832755","article-title":"Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report","volume":"5","author":"Quintana-Ortega","year":"2021","journal-title":"Mod Rheumatol Case Rep"},{"issue":"4","key":"10.1016\/j.amjms.2022.12.001_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102788","article-title":"The seasonality of Dermatomyositis associated with anti-MDA5 antibody: an argument for a respiratory viral trigger","volume":"20","author":"Toquet","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.amjms.2022.12.001_bib0040","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00296-021-04819-1","article-title":"Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry","volume":"41","author":"Mehta","year":"2021","journal-title":"Rheumatol Int"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922004876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922004876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:42:44Z","timestamp":1757702564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962922004876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0002962922004876"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2022.12.001","relation":{},"ISSN":["0002-9629"],"issn-type":[{"type":"print","value":"0002-9629"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and HRCT features of amyopathic dermatomyositis associated with interstitial lung disease: A retrospective study of 128 patients with connective tissue disease-related interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2022.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}